Skip to content

Author

Ahmed A. Abo Elnaga

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Efficacy of anlotinib plus immune checkpoint inhibitors in soft-tissue sarcoma: systematic review and meta-analysis.

BACKGROUND Advanced or metastatic soft-tissue sarcoma (STS) responds poorly to standard chemotherapy. Anlotinib has shown activity across multiple treatment lines, including first-line and maintenance therapies, though monotherapy benefit remains limited. This study aimed to quantify the efficacy of anlotinib plus PD-1...

Ahmed Farid Gadelmawla, Ahmed A. Abo Elnaga, A. Albukhari et al. · 0 citations
Review Aug 2026

Measurements and management of multiple sclerosis-related fatigue: an umbrella review and meta-analysis.

Structured exercise supported by CBT or mindfulness offers the most clinically meaningful relief from MS-related fatigue, and future RCTs should adopt longer follow-up, and use standardized outcome fatigue scales.

Y. Hawas, Ahmed Abdelmageed, M. Abouzid et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.